So the clinical question is obvious
Quick Links AOD-9604 Peptide The Fat-Selective Growth Hormone Fragment Also known as: Anti-Obesity Drug 9604, hGH Fragment 176-191 (modified) Why Researchers Choose AOD-9604 Unlike full-length growth hormone that affects multiple systems, AOD-9604 isolates the fat metabolism region while leaving IGF-1 and insulin pathways untouched
Initial benefits often include smoother texture and improved hydration
Quality concerns : Selfsourcing peptides from online vendors poses significant riskscontamination, inaccurate dosing, substitution, and lack of medical screening for contraindications
Third, marketing personal-use timelines for an unlicensed substance brings the seller inside the medicines framework
Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, glucagon) that remains unlicensed in the UK, with no MHRA approval, no NHS availability, and no BNF listing as of 20242025